Owner Novartis AG

Inventors Baettig, Urs; D'Souza, Anne-Marie; Hunt, Peter; Press, Neil John; Watson, Simon James

Agent Davies Collison Cave

Pub. Number AU-B-2009279123

PCT Pub. Number WO2010/015613

Priority 61/161,627 19.03.09 US; 08161765.6 04.08.08 EP

Filing date 3 August 2009

Wipo publication date 11 February 2010

Acceptance publication date 23 August 2012

C07C 311/48 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 - Sulfonamides

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 213/36 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/12 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 243/08 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 261/08 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 307/14 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/52 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/36 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms